Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia

Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

112 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia trial results

Completed

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

NCT03106779

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • University of Chicago Hospital Chicago, Illinois, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View all 88 locations
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00042003

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations
  • Northside Hospital Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

NCT03625388

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations
  • King Hussein Cancer Center (KHCC) Amman, Jordan
  • Jordan University Hospital (JUH) Amman, Jordan
  • American University of Beirut Medical Center (AUBMC) Beirut, Lebanon
  • The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia
View Trial Details

Related conditions